LRRC8A and neoplasm: Importantly, both KCa3.1 activation and LRRC8A inhibition significantly attenuated high [K+]e-induced CCL2 upregulation (Figure 2, Figure 3, Figure 4 and Figure 5), further supporting their regulatory roles under tumor-like ionic conditions.